Katrine Bosley - Net Worth and Insider Trading

Katrine Bosley Net Worth

The estimated net worth of Katrine Bosley is at least $7 Million dollars as of 2024-04-20. Katrine Bosley is the President and CEO of Editas Medicine Inc and owns about 1,204,966 shares of Editas Medicine Inc (EDIT) stock worth over $7 Million. Details can be seen in Katrine Bosley's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Katrine Bosley has not made any transactions after 2019-01-08 and currently still holds the listed stock(s).

Transaction Summary of Katrine Bosley

To

Katrine Bosley Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Katrine Bosley owns 3 companies in total, including Genocea Biosciences Inc (GNCAQ) , Editas Medicine Inc (EDIT) , and Genocea Biosciences Inc (GGNNQ) .

Click here to see the complete history of Katrine Bosley’s form 4 insider trades.

Insider Ownership Summary of Katrine Bosley

Ticker Comapny Transaction Date Type of Owner
GNCAQ Genocea Biosciences Inc 2015-02-26 director
EDIT Editas Medicine Inc 2019-01-08 director & 10 percent owner & President and CEO
GGNNQ Genocea Biosciences Inc 2015-02-26 director

Katrine Bosley Latest Holdings Summary

Katrine Bosley currently owns a total of 1 stock. Katrine Bosley owns 1,204,966 shares of Editas Medicine Inc (EDIT) as of January 8, 2019, with a value of $7 Million.

Latest Holdings of Katrine Bosley

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
EDIT Editas Medicine Inc 2019-01-08 1,204,966 5.50 6,627,313

Holding Weightings of Katrine Bosley


Katrine Bosley Form 4 Trading Tracker

According to the SEC Form 4 filings, Katrine Bosley has made a total of 0 transactions in Editas Medicine Inc (EDIT) over the past 5 years. The most-recent trade in Editas Medicine Inc is the sale of 12,000 shares on January 8, 2019, which brought Katrine Bosley around $303,240.

Insider Trading History of Katrine Bosley

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Katrine Bosley Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Katrine Bosley Ownership Network

Ownership Network List of Katrine Bosley

No Data

Ownership Network Relation of Katrine Bosley


Katrine Bosley Owned Company Details

What does Genocea Biosciences Inc do?

Who are the key executives at Genocea Biosciences Inc?

Katrine Bosley is the director of Genocea Biosciences Inc. Other key executives at Genocea Biosciences Inc include CHIEF LEGAL & COMPLIANCE OFF Jacquelyn L Sumer , director & President and CEO William D Clark , and CHIEF FINANCIAL OFFICER Diantha Duvall .

Genocea Biosciences Inc (GNCAQ) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Genocea Biosciences Inc (GNCAQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Genocea Biosciences Inc (GNCAQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Genocea Biosciences Inc (GNCAQ)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Genocea Biosciences Inc Insider Transactions

No Available Data

Katrine Bosley Mailing Address

Above is the net worth, insider trading, and ownership report for Katrine Bosley. You might contact Katrine Bosley via mailing address: C/o Editas Medicine, 11 Hurley Street, Cambridge Ma 02141.

Discussions on Katrine Bosley

No discussions yet.